Kernodle & Katon Asset Management Group’s Nu Skin NUS Stock Holding History

Kernodle & Katon Asset Management Group’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$0	Buy	+6	New	+$309	﹤0.01%	359

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Kernodle & Katon Asset Management Group's NUS Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group opened a new position in Nu Skin (NUS) in Q1 2017: 6 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #359 among its holdings.

255 funds tracked by Wall St. Rank hold NUS as of Q1 2017.

Kernodle & Katon Asset Management Group held 6 shares of Nu Skin worth $0 as of Q1 2017.
Nu Skin was a new Kernodle & Katon Asset Management Group position in Q1 2017.
Nu Skin made up ﹤0.01% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #359 holding.
255 funds tracked by Wall St. Rank held Nu Skin as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.